REQUEST A DEMO
Total
USD $0.00
Search more companies

Jhon Bairo Hernandez Jaramillo (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Jhon Bairo Hernandez Jaramillo Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Jhon Bairo Hernandez Jaramillo is a company in Colombia, with a head office in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on April 26, 2000. There are currently 4 (2023) people employed by Jhon Bairo Hernandez Jaramillo. There was a net sales revenue drop of 11.64% reported in Jhon Bairo Hernandez Jaramillo’s latest financial highlights for 2022. There was a total negative growth of 93.61% in Jhon Bairo Hernandez Jaramillo’s total assets over the same period. In 2022, Jhon Bairo Hernandez Jaramillo’s net profit margin decreased by 1.23%.

Headquarters
Cl 28 Sur # 22 A 50
Bogota D.C.; Bogota D.C; Postal Code: 0310

Contact Details: Purchase the Jhon Bairo Hernandez Jaramillo report to view the information.

Basic Information
Total Employees:
Purchase the Jhon Bairo Hernandez Jaramillo report to view the information.
Outstanding Shares:
Purchase the Jhon Bairo Hernandez Jaramillo report to view the information.
Incorporation Date:
April 26, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jhon Bairo Hernandez Jaramillo report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-11.64%
Total operating revenue
-11.64%
Operating profit (EBIT)
-21.62%
Net Profit (Loss) for the Period
-21.62%
Total assets
-93.61%
Total equity
-88.76%
Operating Profit Margin (ROS)
-1.23%
Net Profit Margin
-1.23%
Return on Equity (ROE)
53.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?